The Unique Method Of Emergency Contraception Developed In Hungary
Maybe your like
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation- Clipboard
- My Bibliography
- Collections
- Citation manager
Save citation to file
Format: Summary (text) PubMed PMID Abstract (text) CSV Create file CancelEmail citation
Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email CancelAdd to Collections
- Create a new collection
- Add to an existing collection
Add to My Bibliography
- My Bibliography
Your saved search
Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons- Yes
- No
Create a file for external citation management software
Create file CancelYour RSS Feed
Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link CopyActions
CiteCollectionsAdd to Collections- Create a new collection
- Add to an existing collection
Page navigation
- Title & authors
- Abstract
- MeSH terms
- Substances
- LinkOut - more resources
Abstract
PIP: In Hungary, an important form of emergency contraception (EC) is the pill containing 0.75 mg levonorgestrel, which is marketed by Gedeon Richter under the name Postinor in four-pill packages. Women are instructed to take one pill within an hour of any unprotected act of intercourse, up to four pills per month. The nature of the administration requires that women be in possession of the pills before they need them, and, while Postinor is marketed as an EC, the target market is young, unmarried women who experience infrequent intercourse. When it was first offered a decade ago, Postinor gained widespread use in place of contraception. The product was overused and there was a backlash in the medical community. Thus, the manufacturer changed its packaging instructions and removed the original 10-pill package from the market. While the price of the drug is considered prohibitive for use by adolescents, more than three million pills were sold in the past three years in Hungary and more than 60 million pills were sold in over 20 countries. Clinical studies show a failure rate of less than 1% and relatively few side effects (10-20% nausea and 20-40% bleeding) if not more than four pills per month are used. The World Health Organization is currently conducting trials to compare use of Postinor with the Yuzpe method. Results of these trials will be available in 1996.
PubMed Disclaimer
MeSH terms
- Contraception Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Contraceptive Agents Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Contraceptive Agents, Female Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Contraceptives, Postcoital* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Developed Countries Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Economics Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Europe Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Europe, Eastern Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Evaluation Studies as Topic* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Family Planning Services Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Health Services Accessibility* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Hungary Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Levonorgestrel* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Marketing of Health Services Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Product Packaging* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
Substances
- Contraceptive Agents Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Contraceptive Agents, Female Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Contraceptives, Postcoital Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Levonorgestrel Actions
- Search in PubMed
- Search in MeSH
- Add to Search
LinkOut - more resources
Miscellaneous
- NCI CPTAC Assay Portal
- Clipboard
- Save
- My Bibliography
- Collections
- Citation Manager
NCBI Literature Resources
MeSH PMC Bookshelf Disclaimer
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
Tag » What Does Postinor 10 Work For
-
Postinor Oral Contraceptive - National Museum Of American History
-
How Does POSTINOR Work?
-
How To Take POSTINOR?
-
Postinor-1 - NPS MedicineWise
-
Postinor Use Among Young Women In Southwestern Nigeria - Jstor
-
Difference Between Postinor 1 And Postinor 2
-
Levonorgestrel Tablet Contraceptives - Uses, Side Effects, And More
-
Difference Between Postinor 10, Postinor 4, Postinor 2 And Postinor 1
-
22 Most Common Questions About Taking Postinor 2 Effectively
-
Postinor-2 (levonorgestrel) Emergency Contraceptive Information
-
[PDF] New Zealand Consumer Medicine Information Postinor®-1 - Medsafe
-
[PDF] Package Leaflet: Information For The User
-
The Morning-after Pill Following Unprotected Sex
-
Postinor-2 Full Prescribing Information, Dosage & Side Effects - MIMS